Alnylam Pharmaceuticals Aktie
254,10
EUR
-1,10
EUR
-0,43
%
290,18
USD
-0,21
USD
-0,07
%
Werbung
Alnylam Pharmaceuticals Aktie Analyse
20.08.08 | Alnylam Pharmaceuticals underperform | Leerink Swann LLC | |
03.03.08 | Alnylam Pharmaceuticals underperform | Needham & Company, LLC |
Werbung
Werbung